Follow
Robert Kruse, MD, PhD
Robert Kruse, MD, PhD
Harvard Medical School
Verified email at bwh.harvard.edu - Homepage
Title
Cited by
Cited by
Year
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China
RL Kruse
F1000Research 9, 2020
3872020
Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells
T Shum, B Omer, H Tashiro, RL Kruse, DL Wagner, K Parikh, Z Yi, ...
Cancer discovery 7 (11), 1238-1247, 2017
2392017
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients
RL Kruse, JR Kramer, GL Tyson, Z Duan, L Chen, HB El-Serag, F Kanwal
Hepatology 60 (6), 1871-1878, 2014
932014
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice
RL Kruse, T Shum, H Tashiro, M Barzi, Z Yi, C Whitten-Bauer, X Legras, ...
Cytotherapy 20 (5), 697-705, 2018
802018
Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model
B Bissig-Choisat, L Wang, X Legras, PK Saha, L Chen, P Bell, ...
Nature communications 6 (1), 7339, 2015
642015
Diagnosis and management of pulmonary infection due to Rhodococcus equi
WV Lin, RL Kruse, K Yang, DM Musher
Clinical Microbiology and Infection 25 (3), 310-315, 2019
612019
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
G Billioud, RL Kruse, M Carrillo, C Whitten-Bauer, D Gao, A Kim, L Chen, ...
Journal of Hepatology 64 (4), 781-789, 2016
602016
Corynebacteria as a cause of pulmonary infection: a case series and literature review
K Yang, RL Kruse, WV Lin, DM Musher
Pneumonia 10, 1-8, 2018
502018
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities
T Shum, RL Kruse, CM Rooney
Expert opinion on biological therapy 18 (6), 653-664, 2018
342018
Wilson disease: update on pathophysiology and treatment
S Dev, RL Kruse, JP Hamilton, S Lutsenko
Frontiers in cell and developmental biology 10, 871877, 2022
292022
Drug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects.
RL Kruse, K Vanijcharoenkarn
Allergy, 2017
242017
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res. 2020; 9: 72
RL Kruse
Epub 2020/01/31. doi: 10.12688/f1000research. 22211.2. PubMed PMID: 32117569, 0
20
A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2
RL Kruse, Y Huang, H Smetana, EA Gehrie, TK Amukele, AAR Tobian, ...
Biochemical and biophysical research communications 553, 165-171, 2021
182021
Isohemagglutinin titering performed on an automated solid‐phase and hemagglutinin‐based analyzer is comparable to results obtained by manual gel testing
K Lally, RL Kruse, H Smetana, R Davis, A Roots, C Marshall, PM Ness, ...
Transfusion 60 (3), 628-636, 2020
172020
In situ liver expression of HBsAg/CD3-bispecific antibodies for HBV immunotherapy
RL Kruse, T Shum, X Legras, M Barzi, FP Pankowicz, S Gottschalk, ...
Molecular therapy Methods & clinical development 7, 32-41, 2017
162017
Intracellular translation of circular RNA
R Kruse
US Patent 9,822,378, 2017
112017
Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research, 2020; 9
RL Kruse
9
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy
RL Kruse, J Albayda, SO Vozniak, CE Lawrence, R Goel, ...
Journal of Clinical Apheresis 37 (3), 253-262, 2022
82022
A hemagglutination-based semiquantitative test for point-of-care determination of SARS-CoV-2 antibody levels
RL Kruse, Y Huang, A Lee, X Zhu, R Shrestha, O Laeyendecker, ...
Journal of clinical microbiology 59 (12), 10.1128/jcm. 01186-21, 2021
72021
Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection
RL Kruse, X Legras, M Barzi
Virus research 292, 198224, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20